BiotechTube

Rexlemestrocel-L + HA mixture + Saline

Phase 3Recruiting
0 views this week 0 watching⚡ Active
Interest: 41/100
41
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Degenerative Disc Disease

Conditions

Degenerative Disc Disease

Trial Timeline

Jul 3, 2024 → Oct 1, 2027

NCT ID
NCT06325566

About Rexlemestrocel-L + HA mixture + Saline

Rexlemestrocel-L + HA mixture + Saline is a phase 3 stage product being developed by Mesoblast for Degenerative Disc Disease. The current trial status is recruiting. This product is registered under clinical trial identifier NCT06325566. Target conditions include Degenerative Disc Disease.

What happened to similar drugs?

1 of 5 similar drugs in Degenerative Disc Disease were approved

Approved (1) Terminated (1) Active (3)
✅PimavanserinAcadia PharmaceuticalsApproved
❌LatozinemabAlectorPhase 3
🔄Pimavanserin + PlaceboAcadia PharmaceuticalsPhase 3
🔄PimavanserinAcadia PharmaceuticalsPhase 3
🔄Rexlemestrocel-L + Rexlemestrocel-L + HA Mixture + PlaceboMesoblastPhase 3

Hype Score Breakdown

Clinical
17
Activity
15
Company
9
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT06325566Phase 3Recruiting

Competing Products

17 competing products in Degenerative Disc Disease

See all competitors
ProductCompanyStageHype Score
LatozinemabAlectorPhase 3
22
YH14618 + YH14618 + YH14618 + PlaceboYuhanPhase 1/2
32
Placebo + YH14618YuhanPhase 2
35
Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial CellsAstellas PharmaPhase 1/2
39
ONO-2808 + PlaceboOno PharmaceuticalPhase 1
29
Pimavanserin + PlaceboAcadia PharmaceuticalsPhase 3
37
PimavanserinAcadia PharmaceuticalsApproved
47
PimavanserinAcadia PharmaceuticalsPhase 3
37
Lumbar Interbody Fusion with Autograft + Lumbar Interbody Fusion with NeoFuse + Lumbar Interbody Fusion with NeoFuseMesoblastPhase 2
29
NeoFuseMesoblastPhase 2
29
Single Dose MPCs Injection + Single Dose MPCs InjectionMesoblastPhase 2
29
Rexlemestrocel-L + Rexlemestrocel-L + HA Mixture + PlaceboMesoblastPhase 3
34
NeoFuseMesoblastPhase 1/2
26
NeoFuseMesoblastPhase 1/2
26
PLF with NeoFuse + PLF with NeoFuse + PLF with NeoFuseMesoblastPhase 1/2
18
Use iliac bone graft + use bone morphogenetic protein + use bone derived allograft MSCs + Use adipose tissue derived MSCs + Use amnion/placental derived MSCsBrain BiotechPhase 2/3
28
Blood sampling, skin biopsy, excreta sampling, lumbar punctureBrain BiotechPre-clinical
23